Delivery Order SPE2DB25D3001-SPE2DB26FQTQE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,255.36 to supply Varivax vaccine with diluents. The contract, awarded on October 21, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 12, 2025. This award was made on a competitive basis with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The place of...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,053.01 for Varivax vaccine with diluents on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award uses firm fixed pricing and includes no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this contract represents a transactional draw against a larger procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varivax vaccine with diluents, with a contract ceiling value of $268,348.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The work is scheduled for completion by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Varivax vaccine with diluents, valued at $1,053.01. The contract is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $2,105.92 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of June 17, 2025. This firm fixed-price delivery order represents a non-competitive procurement issued under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,052.96 and an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competition, represents a routine pharmaceutical procurement through DLA's medical supply chain. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Varivax vaccine with diluents, valued at $3,756.02 with a firm fixed price contract type. The order is scheduled for completion by October 17, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, valued at $2,106.02, with an ultimate completion date of July 18, 2025. This is a firm fixed-price delivery order issued without set-aside designation, reflecting a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB26FQTQEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $2,106.02 and an ultimate completion date of November 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, medications, and medical supplies across multiple therapeutic domains. The Varivax delivery represents routine pharmaceutical fulfillment in support of Defense Health Agency and other federal healthcare system requirements.